What's Inside

In the US, increased legalization has reshaped the narrative around cannabis and psychedelic mushrooms over the past few years. What were once underground, stigmatized substances are now readily available to many Americans via regulated markets.

Coresight Research analyzes the shifting regulatory and retail landscape surrounding cannabis and psychedelic mushrooms in the US, providing a data-driven snapshot of current legalization trends, consumer behavior and purchasing patterns.

Data in this research report include:

• US legal cannabis market size and year-over-year growth rates, 2024, 2025E and 2029E
• Proprietary survey data on which US consumers buy cannabis and psychedelic-mushroom products by age, income, gender and location
• Share of US consumers’ budgets that they spend on cannabis and psychedelic-mushroom products
• Top reasons why consumers purchase cannabis and psychedelic-mushroom products

Companies mentioned in this report include/are: CVS Health, DisplayDispensary.com, Rocky Mountain Cannabis, The Vitamin Shoppe, Walgreens Boots Alliance, Walmart

Other relevant research:

• Health Check: Quantifying the Physical and Mental Health of the US Consumer
• Market Navigator: US Healthcare—Evolving To Become More Personalized and Consumer-Focused
• US Cannabis Survey 2022: Marijuana Usage Up After Legalization